MW
Insider selling
Mark Wilterding sold $54K of RxSight, Inc. (RXST) stock
Mark Wilterding, Chief Financial Officer of RxSight, Inc. (RXST), sold 7,765 shares of RXST stock worth $54K, per an SEC Form 4 filed Sep 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 31, 2026, 3 days before it was made public.
RXST has moved -29.9% since the trade date, from $7.33 to $5.14 (Sep 21, 2026 close).
- Traded
- Aug 31, 2026
- Disclosed
- Sep 3, 2026
- Filing delay
- 3 days
- Price since
- -29.9%
- Role
- Chief Financial Officer
- Source
- SEC Form 4
More RXST insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.